Prostate cancer detection kit TPS®

for ovarian cancerfor breast cancerfor prostate cancer

The tumor marker TPS® is a reliable indicator of tumor cell activity particularly useful in patient manage-ment for different carcinomas. Compared with conventional tumor mass markers, the activity marker TPS® provides the clinician with earlier signals about the course of the disease. TPS® is particularly useful in treatment monitoring and surveillance of patients with epithelial cell carcinomas e.g. breast, prostate and ovarian cancer. A TUMOR MARKER FOR PATIENT MANAGEMENT 1. Particularly useful in patient management for carcinomas of different origins 2. Provides the clinician with earlier signals about the course of the disease when compared to clinical criteria 3. In combination with conventional tumor mass markers gives a more complete clinical picture, thus making it possible for the clinician to act with greater insight 4. Serves as a tool for the prediction of treatment outcome 5. High sensitivity for metastatic disease 6. Supports therapeutical decisions to optimize patient management and improve the cost/benefit 7. Reliable indicator of tumor cell activity, especially useful in treatment monitoring and patient follow-up. Breast cancer TPS® has consistently been found to be a good marker for prediction of prognosis and response to therapy. By serial testing, TPS® can be used for therapy control and follow-up of breast cancer patients. The sensitivity of TPS® to detect progressive disease is particularly high in patients with metastatic spread. Pretreatment TPS® levels have been shown to be related to prognosis and clinical outcome.